» Authors » Palanivel Chinnakali

Palanivel Chinnakali

Explore the profile of Palanivel Chinnakali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 718
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar K, Dorairajan G, Chinnakali P, Durai V
Indian J Public Health . 2024 Dec; 68(4):549-551. PMID: 39670938
This study was undertaken to assess the change in menstrual cycle interval, duration, amount of flow, and new onset of pain after the first and second dose of Covaxin vaccination...
2.
Govindan D, Chinnakali P, Sarkar S, Soundappan G
Indian J Public Health . 2024 Dec; 68(4):526-533. PMID: 39670934
Background: In India, there is significant attrition in the cascade of care for tuberculosis (TB) in the public health sector. Pharmacy being the first point of contact for the majority...
3.
Subramanian S, Gnanadhas J, Sarkar S, Rajaram M, Prakashbabu S, Chinnakali P
BMJ Open Respir Res . 2024 Dec; 11(1. PMID: 39645238
Background: The sustainable development goal (SDG) 3.3.2 prompted India to devise the National Strategic Plan 2017-2025, targeting tuberculosis (TB) eradication by 2030. The prevention pillar of this plan emphasises on...
4.
Nagaram S, Charles P, Nisha Y, Stephen N, Hanumanthappa N, Parameswaran S, et al.
BMC Nephrol . 2024 Oct; 25(1):378. PMID: 39455940
Background: Podocytopathies, including minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and collapsing glomerulopathy (CG), are kidney diseases that damage glomerular podocytes, leading to heavy proteinuria and nephrotic syndrome (NS)....
5.
Zachariah R, Thekkur P, Nair D, Davtyan H, Tripathy J, Chinnakali P, et al.
Indian J Med Res . 2024 Oct; 159(3 & 4):308-313. PMID: 39361804
No abstract available.
6.
J A, R M, Chinnakali P
Indian J Tuberc . 2024 Jul; 71 Suppl 1:S91-S96. PMID: 39067963
Setting: On a programmatic basis, a new regimen was introduced in the National Tuberculosis Elimination Programme for isoniazid monoresistant tuberculosis in a few states in India. Objective: To describe the...
7.
Nagaram S, Charles P, Nandeesha H, Parameswaran S, Chinnakali P, Ganesh R
Cureus . 2024 Jul; 16(6):e62143. PMID: 38993428
Background and objective Nephrotic syndrome is a significant worldwide health concern impacting millions of people and is marked by heavy proteinuria, edema, and decreased serum levels of albumin. Albuminuria arises...
8.
Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, et al.
Clin Infect Dis . 2024 Jul; 79(4):1034-1038. PMID: 38991034
In this prospective cohort of 2006 individuals with drug-susceptible tuberculosis in India, 18% had unfavorable treatment outcomes (4.7% treatment failure, 2.5% recurrent infection, 4.1% death, 6.8% loss to follow-up) over...
9.
Yadav A, Sarkar S, Chinnakali P, Soundappan G
Indian J Public Health . 2024 Jun; 67(4):626-631. PMID: 38934831
Background: The shift of focus toward pandemic control had an impact on public health issues that need to be addressed. As the impact may vary in the different areas based...
10.
Nagaram S, Charles P, Nandeesha H, Stephen N, Parameswaran S, Chinnakali P, et al.
Cureus . 2024 May; 16(4):e58506. PMID: 38765394
Background and objective Membranous glomerulonephritis (MGN) is a common cause of adult nephrotic syndrome. Tumor necrosis factor-α (TNF-α) is a proinflammatory cytokine that signals by attaching to TNF receptors. TNF-α...